Company intelligence / Profile preview

MRC Laboratories

Cincinnati, Ohio, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Molecular Research Center (MRC) is a life science company specializing in the development and manufacture of innovative reagents for the isolation and analysis of RNA, DNA, and proteins. Founded in 1989 by Dr. Piotr Chomczynski, the inventor of the widely used TRI Reagent method, the company has established itself as a leader in nucleic acid purification technologies. MRC's product portfolio includes the TRI Reagent family, DNAzol, and RNAzol, which are utilized globally in academic research, clinical diagnostics, and biotechnology applications. The company focuses on providing high-yield, high-purity extraction solutions that simplify molecular biology workflows.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on MRC Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MRC Laboratories.

Explore the full profile